Different prognostic values of KRAS exon 2 sub-mutations and BRAF V600E mutation in microsatellite stable (MSS) and unstable (MSI) stage III colon cancer: an ACCENT/IDEA pooled analysis of 7 trials.

🔗 Access full article via Annals of Oncology

The prognostic value of KRAS and BRAFV600E mutations in stage III CC remains controversial and has never been clearly analyzed in patients with MSI-H tumors due to sample size limitations . Data are also lacking for